Show results for
  • Sygnature
  • News
  • Drug Discovery
  • Therapeutic Areas
  • Events
  • Vacancies

Sygnature Discovery opens doors to LATi members

On the 15th October 2015, Sygnature Discovery will be hosting an event, entitled ‘A Global Reputation for Drug Discovery Excellence’ for LATi members. An organisation which supports businesses involved in the innovative use of science and technology.

Hot on the heels of the announcement that Sygnature Discovery will be moving into a new ‘flagship’ facility at BioCity in Nottingham, the event will give delegates an opportunity to learn more about the company, its on-going expansion plans, many successes to date as well as a tour of its research facility.

The LATi visit and tour will include:

  • An overview of Sygnature Discovery
  • Case history – how Sygnature Discovery collaborated with a US biotech to deliver a novel therapeutic agent for metabolic and oncologic disorders currently undergoing clinical trials
  • An opportunity to ask questions
  • Guided tour of the facility
  • Drinks & networking

The event is free to LATi members, but also open to non members.

Latest News

View All

Sygnature Discovery completes acquisition of SB Drug…

Sygnature Discovery partners the Oncology Development Programme…

Sygnature Discovery deploys Iktos’ AI technology ‘Makya™’

Sygnature Discovery acquires Peak Proteins

Get in Touch

For more details on how we can provide innovative support to your project please use this contact form.

CTA Form

Areas of interest

Discovery Discipline
Therapeutic Areas
The information you supply will be processed in accordance with the General Data Protection Regulation (EU) 2016/679. For further details about how Sygnature Discovery collects, uses and stores personal data, please refer to our Website Privacy Notice available here.